AAV-103

N/A

Report date: 2023/12/11 18:14:41

Base Information

Drug NameAAV-103
Drug Alias NameAAV-103DB-103(Decibel Therapeutics)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGap junction beta-2 protein gene transference
TargetsGap junction beta-2 protein
Therapy Area/IndicationsDeafness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDecibel TherapeuticsRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDecibel Therapeutics
Inactive CompaniesN/A
Active IndicationsDeafness
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A